Phase 1 Study Of Retifanlimab (Anti-Pd-1) And Incb001158 (Arginase Inhibitor), Alone Or In Combination, In Solid Tumors

ANNALS OF ONCOLOGY(2021)

引用 5|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要